Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions

Nov.18.2024
Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Shenzhen police, in collaboration with the State Tobacco Monopoly Administration, successfully cracked a major case involving counterfeit ALIBARBAR vapes.

Statement:

On November 22, 2Firsts received a letter from Shenzhen Xiyue Intelligent Technology Manufacturing Co., Ltd. The letter stated that the products shown in the original and counterfeit comparison images in the article "ALIBARBAR Counterfeit Case," first published on sznews were not produced by the company. However, the vape production license number displayed in the images belongs to the company and is suspected of being misappropriated.

 

Since sznews has removed the images, 2Firsts has also deleted them. This statement is issued for clarification.


Shenzhen police and the State Tobacco Monopoly Administration seized tens of thousands of counterfeit ALIBARBAR vapes worth millions, cracking a major case and targeting illegal counterfeit sales, sznews reported on November 15.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Crime scene | Image source: sznews

 

Law enforcement in Shenzhen conducted simultaneous raids across multiple locations in one district, shutting down three counterfeit vape production and sales operations. The raids resulted in the seizure of tens of thousands of fake ALIBARBAR vapes, along with manufacturing equipment, raw materials, and packaging materials.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Scene of the crime | Image source: sznews

 

During interrogation, the suspects confessed to the crimes of producing and selling counterfeit vapes. They admitted to manufacturing large quantities of fake vapes for high profits and distributing them to overseas markets. The case is currently under further investigation.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Crime scene | Image source: sznews

 

Shenzhen police announced their commitment to cracking down on counterfeit production and sales, working closely with the State Tobacco Monopoly Administration and other authorities to protect consumer rights. 

 

They also advised consumers to buy vape products only from official channels, warning that using counterfeit products could lead to serious health risks.

R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13